Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023
07 juin 2023 02h01 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...